Ceva will share its latest innovations and expert knowledge in poultry vaccination, equipment and services. The Ceva stand will provide practical and technical information to help poultry producers to improve their performance using new technology products such as Transmune®, Vectormune® ND and Egginject®

One hot topic sure to be discussed at the congress is the subject of avian influenza (AI). The disease has proved to be a major threat for the global poultry industry, disrupting international trade and inducing heavy economical losses in infected flocks. Nevertheless, there is still a debate raging about the necessity of AI vaccination.

In that context, during the congress, Ceva will hold a symposium with leading global figures, including the USDA (who have recently been at the forefront of the battle), to address the current AI situation and discuss the differing industry perspectives. The symposium will be entitled: “Avian Influenza – The value of vaccination in changing times”.  Indeed, Ceva’s vector vaccine Vectormune® AI offers a new way to control this disease in vaccinating countries around the world.

To find out more visit: www.ceva.comwww.avian-influenza-vaccines.com

-ENDS-

Ceva booth n°10

 

Ceva symposium

Avian influenza : the value of vaccination in changing times

Thursday, September 7^th

8:00 – 10:00 am

Auditorium 1

Contacts Presse

Agence Passerelles	Ceva Santé Animale
Anne Laure Guillaume & Isabelle Latour-Gervais Tél. +33 (0)5 56 20 66 77 E-mail : ceva@passerelles.com	Martin Mitchell Group Communications Director Tél. +33 (0)5 57 55 40 80 E-mail: martin.mitchell@ceva.com

>> Download the Press Release in PDF: